文献速递胃肠外科肝胆胰外科围术期管理与 ERAS

直肠癌前切除术后袢式回肠造口关闭时使用腹膜后合成补片与生物补片预防切口疝(Preloop试验)

Prevention of incisional hernia with retrorectus synthetic mesh versus biological mesh following loop ileostomy closure (Preloop trial).
PubMed 文献 · Br J Surg · 2024-01-01

Preloop试验为多中心RCT,纳入直肠癌前切除术后袢式回肠造口关闭患者,比较腹膜后合成补片与生物补片预防切口疝。2018年11月至2021年9月随机102例,97例接受预定分配。10个月随访时两组临床诊断切口疝各1例(2%)(P=0.950),CT确诊切口疝各1例(P=0.949),其他并发症、再手术率、手术时间和住院时间两组无差异。结论认为合成补片在疗效和安全性上与生物补片相当。

要点

  • 直肠癌前切除术后袢式回肠造口关闭时,腹膜后合成补片与生物补片预防切口疝的临床和影像学发生率均低且相近。
  • 两组30天内其他并发症、再手术率、手术时间和住院时间无差异。
  • 合成补片在污染手术部位的安全性似乎与生物补片相当。

核心结论

  • 在袢式回肠造口关闭时,合成补片在预防切口疝的疗效和安全性方面似乎与生物补片相当。

研究设计与样本

  • Preloop试验为多中心随机对照试验,纳入直肠癌前切除术后行袢式回肠造口关闭的患者,随机分配接受腹膜后合成补片或生物补片以预防切口疝。
  • 2018年11月至2021年9月共随机102例患者,其中97例接受了预定分配。
  • 主要结局为30天内手术部位感染,以及10个月时临床或影像学切口疝发生率。

主要发现

  • 10个月随访时,90例患者接受了临床评估,88例接受了影像学评估。
  • 临床诊断切口疝每组各1例(2%)(P=0.950),CT确诊切口疝每组另各1例(P=0.949)。
  • 其他并发症数量、再手术率、手术时间和住院时间两组间无差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The rate of incisional hernia after closure of a temporary loop ileostomy is significant. Synthetic meshes are still commonly avoided in contaminated wounds. The Preloop trial was a multicentre RCT designed to evaluate the benefits of synthetic mesh in incisional hernia prevention, and its safety for use in a contaminated surgical site compared with biological mesh. METHODS: Study patients who underwent closure of a loop ileostomy after anterior resection for rectal cancer were assigned to receive either retrorectus synthetic or biological mesh to prevent incisional hernia. The primary outcomes were surgical-site infections within 30 days, and clinical or radiological incisional hernia incidence at 10 months. Secondary outcomes were reoperation rate, operating time, duration of hospital stay, other complications within 30 days of surgery, 5-year quality of life measured by RAND-36, and incisional hernia incidence within 5 years of follow-up. RESULTS: Between November 2018 and September 2021, 102 patients were randomised, of whom 97 received the intended allocation. At 10-month follow-up, 90 patients had undergone clinical evaluation and 88 radiological evaluation. One patient in each group (2 per cent) had a clinical diagnosis of incisional hernia (P = 0.950) and one further patient in each group had a CT-confirmed incisional hernia (P = 0.949). The number of other complications, reoperation rate, operating time, and duration of hospital stay did not differ between the study groups. CONCLUSION: Synthetic mesh appeared comparable to biological mesh in efficacy and safety for incisional hernia prevention at the time of loop ileostomy closure. REGISTRATION NUMBER: NCT03445936 (http://www.clinicaltrials.gov).

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Mäkäräinen EJ, Wiik HT, Kössi JAO, et al. Prevention of incisional hernia with retrorectus synthetic mesh versus biological mesh following loop ileostomy closure (Preloop trial). Br J Surg. 2024. PMID: 37944025. doi:10.1093/bjs/znad362

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。